We build deviation management systems to EU GMP guidelines (EudraLex Volume 4) and ICH Q10: SOP, risk triage, root cause analysis, OOS handling and trending. The bottleneck is rarely capturing but closing on time with a defensible root cause: triage, investigation and CAPA in sequence decide audit safety.
Overview
System design, OOS investigation and backlog reduction · EU GMP (EudraLex Volume 4), ICH Q10, ICH Q9(R1)
Last updated: September 18, 2026
A deviation is any departure from an approved instruction, specification or requirement. The EU GMP Guide (EudraLex Volume 4) requires that such deviations be recorded, assessed, investigated and documented.
Industries
Services
We design the deviation process and write the SOP in line with EU GMP Chapter 1 and ICH Q10: classification by criticality, risk triage, timelines, escalation paths and responsibilities. The deliverable is an approvable SOP including a classification matrix and a set of forms.
We define the investigation procedure required by EU GMP Chapter 6 for OOS and OOT results, in practice with separate laboratory and production phases. You receive an OOS SOP with a decision tree that specifies when a result is rejected, confirmed or subject to extended investigation.
We train the functions involved in root cause analysis, assessment and documentation and embed the process in day-to-day operations. At the end there is completed training with training records and an RCA methodology aid for ongoing use.
How we work together
Robust deviation management is decided in the first hours after a report comes in. At the start, triage decides whether a deviation is critical, major or minor, and thereby how deeply it must be investigated and how quickly it must be closed.
If triage is skipped, every case runs through the same process; minor deviations tie up the same investigation capacity as critical ones, and the deadlines for the critical cases slip first.
Only after triage does root cause analysis take hold, the depth of which must match the criticality under ICH Q9(R1), and only from a defensible root cause can a CAPA be derived. If the deviation is closed before the cause is established, the CAPA lacks its foundation, and the case recurs.
The typical difficulty is not recording but closing. The backlog of overdue deviations builds up at the closing step, turns into a finding in inspections under EU GMP Chapter 1 and is at the same time a symptom: a quality system that generates more deviations than it can process.
Because a growing backlog becomes a system symptom in its own right, we act on two fronts: we clear the existing backlog on a risk basis and align the ongoing process so that no new one builds up.
Aggregated trending closes the loop: it makes recurring causes visible that remain hidden when cases are viewed individually, and it translates deviation management from reactive mandatory documentation into the continual improvement envisaged by EU GMP Chapter 1.
| Feature | Deviation | CAPA |
|---|---|---|
| Object | individual event: departure together with investigation and root cause analysis | corrective and preventive actions derived from it |
| Purpose | delivers the root cause | eliminates the cause, prevents recurrence |
Our approach
Step
Result
Triage & Initial Assessment
Deviation recorded, classified by criticality and immediate containment actions defined; risk-based prioritization in line with ICH Q9(R1) is in place.
Investigation & RCA
Structured root cause analysis with a documented cause whose depth matches the criticality; OOS/OOT investigation completed where needed.
CAPA Derivation
Corrective and preventive actions derived from the root cause and handed over to the CAPA system, with effectiveness checks planned.
Closure & Trending
Deviation closed on time and transferred into trending; recurring patterns become visible and feed back into the quality system.
Common pitfalls
The root cause analysis stays at the surface.
Human error is recorded as the root cause without looking for the systemic cause. The same deviation recurs, the CAPA does not take hold, and the audit reveals the pattern of recurring cases.
Risk-based triage is missing.
Every deviation goes through the same elaborate process, critical and trivial cases are treated alike. The system overloads, deadlines slip, and the backlog of overdue deviations grows into a finding under EU GMP Chapter 1.
With an OOS result, the laboratory investigation is skipped.
A suspicious result is classified as a production error without a clean laboratory investigation, or vice versa. Without that separation, the later assessment is open to challenge and the rejected result is not defensibly justified.
Deviation and CAPA are conflated.
The deviation is closed before the corrective and preventive actions are defined and their effectiveness is planned. The line between the individual deviation and the CAPA derived from it blurs, and traceability is lost.
Trending does not happen.
Individual deviations are closed but never evaluated in aggregate. Recurring causes remain invisible, the quality system does not learn, and the continual improvement envisaged by EU GMP Chapter 1 comes to nothing.
Quality Management & Compliance
In a first call we assess your situation and say what needs clarifying first in your case. Without obligation, reply usually within one working day.
FAQ
Image notice: The images on this page were generated using artificial intelligence. They do not depict real people, places, or events.
Life Science Journal
New requirements, authority decisions and practice notes. Once a month, unsubscribe any time.
Case Studies
Related insights
All insights →CAPA Management →
The corrective and preventive actions derived from deviations, together with effectiveness checks
Complaint Management →
Complaints as a further source of deviations and CAPA in the quality system
GMP Consulting (Good Manufacturing Practice) →
The pharmaceutical quality system under EU GMP in which deviation management is embedded
Inspection Readiness →
Preparing for inspections in which open deviations and backlogs are examined
Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.
Prefer direct? +49 89 4161170-0
info@theentourage.de
